Related Experiment Video
Updated: Aug 3, 2026
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Lercanidipine-induced chylous ascites: Case report and literature review
J E Basualdo1, I A Rosado1, M I Morales2
1Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
What Is Known And Objective:
Chylous ascites is a rare condition. The most frequent causes are lymphomas, solid malignancies, abdominal trauma and cirrhosis. Isolated case reports describe the relationship between calcium channel blockers (CCB) and chyloperitoneum. Lercanidipine is a third-generation dihydropyridine with low rate of adverse events. We describe a case of lercanidipine-induced chylous ascites.
Case Summary:
An 80-year-old white female with hypertension treated with lercanidipine, developed chylous ascites and abdominal pain after the dosage of the CCB was doubled. The initial suspicion was a hidden neoplasm, but after a thorough research, no apparent cause was detected and the symptoms resolved after the drug was suspended.
What Is New And Conclusion:
Calcium channel blockers should be considered as possible causes in cases of chyloperitoneum of unknown aetiology.
